Remote patient monitoring (RPM) collects health information—such as blood pressure, glucose levels, weight, heart rate, or oxygen saturation—from patients outside traditional care settings and transmits it to a care team. The real cost of skipping or disregarding RPM data is not simply a missed reading: it can mean delayed recognition of clinical deterioration, avoidable emergency care, lost opportunities to adjust treatment, and weakened patient trust. The risk is not identical for every alert or patient, and evidence of RPM’s effectiveness varies by program and condition. But studies, clinical guidance, and Medicare’s billing rules all point to the same operational requirement: data must be reviewed, interpreted, and acted on within a defined care process.
What the cost of skipping remote patient monitoring data means
The “cost” of skipped RPM data is the potential clinical, operational, financial, and human impact when relevant patient-generated information is not received, reviewed, or acted upon in time. The U.S. Centers for Medicare & Medicaid Services (CMS) defines remote physiologic monitoring through services involving the collection and transmission of physiologic data from a patient to a provider for treatment management. That definition makes monitoring more than device deployment: the information has to enter a clinical workflow.
Skipped data can take several forms: a reading never transmitted because of a device or connectivity problem; an alert that is not reviewed; a concerning trend that is not escalated; or a reading treated as reliable despite poor measurement technique. These are distinct failure points, and each calls for a different remedy. A missing reading is not proof that a patient is stable, just as an isolated abnormal reading is not automatically proof of an emergency.
The scale of potential exposure is significant. The U.S. Centers for Disease Control and Prevention reports that about 805,000 people in the United States have a heart attack each year, while the American Heart Association identifies high blood pressure as a major risk factor for cardiovascular disease. RPM does not prevent every acute event, but timely trends can help care teams identify changes and respond according to an individualized plan.
How skipped RPM data creates clinical risk
Clinical risk arises when an unreviewed reading or missing trend delays a decision that could affect treatment. The National Institute of Standards and Technology’s work on health information systems emphasizes that clinical technology depends on reliable data flows, secure systems, and appropriate human use. In practice, an RPM number becomes useful only when its context is understood: the patient’s baseline, symptoms, medicines, measurement conditions, and care plan.
Missed deterioration and delayed escalation
A deterioration signal is a meaningful change from a patient’s usual condition, such as a sustained rise in blood pressure, increasing weight in someone with heart failure, or worsening oxygen saturation. If repeated readings are ignored, the team may lose time to contact the patient, check symptoms, arrange an assessment, or direct the patient to urgent care. The Agency for Healthcare Research and Quality’s patient-safety resources stress the importance of reliable communication and escalation processes when clinical concerns emerge.
The importance of a trend can be illustrated by heart failure monitoring. A sudden weight increase may indicate fluid retention, but weight alone cannot diagnose worsening heart failure. A care team may need to consider symptoms, medication adherence, diet, and the patient’s prescribed thresholds. Skipping the data removes one possible early-warning signal; acting on it requires clinical judgment rather than an automatic assumption.
False reassurance from missing or incomplete readings
Missingness is itself a data-quality issue. A patient who has stopped transmitting readings may be well, confused about the equipment, unable to connect, or too unwell to participate. Treating silence as normal can create false reassurance. A sound program distinguishes “no data received” from “normal data received” and sets rules for outreach when expected measurements are absent.
The National Committee for Quality Assurance and other health-care quality organizations emphasize that measures must be interpreted in context, with clear definitions and reliable collection methods. For RPM teams, that means documenting expected measurement frequency, identifying transmission failures, and deciding when a missed check-in warrants a call rather than an automated reminder.
Measurement errors and alert fatigue
Not every unusual value represents a true clinical change. Incorrect cuff size, poor positioning, device error, or a reading taken immediately after activity can produce misleading results. The American Heart Association recommends proper technique for home blood-pressure measurements, including using a validated monitor, sitting quietly, and positioning the arm correctly. Reviewing data therefore includes checking plausibility and, when appropriate, asking the patient to repeat the measurement.
At the same time, excessive or poorly tuned alerts can overwhelm clinicians. The U.S. Food and Drug Administration’s guidance on clinical decision-support software distinguishes software functions from the clinical decision-making that remains the responsibility of health professionals. Programs should prioritize alerts by urgency, define who receives them, and avoid making staff sift through a flood of low-value notifications.
How missed RPM data affects costs, workload, and access
The financial effect of missed monitoring is difficult to reduce to one universal dollar figure. It depends on the condition, patient population, program design, local reimbursement, and whether a timely intervention would have changed the outcome. Still, the economic pathways are clear: delayed care may contribute to avoidable hospital use, while poorly designed monitoring can add staff burden without producing meaningful clinical benefit.
Potentially avoidable acute-care use
A missed trend can postpone a medication adjustment or clinical assessment until symptoms become more severe. In some cases, earlier contact may help manage a problem in an outpatient setting; in others, urgent evaluation remains necessary. The Centers for Medicare & Medicaid Services and the Agency for Healthcare Research and Quality both frame care coordination and prevention of avoidable complications as important health-system goals, but RPM should not be presented as a guaranteed way to prevent admissions.
A frequently cited example is the Whole System Demonstrator, a large English telehealth and telecare trial. Its findings, published in The New England Journal of Medicine in 2012, reported lower mortality and emergency-admission rates in the telehealth group over the study period. The trial evaluated a broader telehealth intervention rather than every modern RPM model, so its results should not be assumed to apply identically to all devices, diseases, or programs.
Staff time and reimbursement exposure
RPM can shift work from in-person visits to device onboarding, data review, patient outreach, documentation, and escalation. If data are skipped, staff may later spend more time reconstructing events or responding to a crisis. If every reading is reviewed without prioritization, staff can also become overloaded. The operational objective is not to inspect every number in the same way; it is to define clinically appropriate review intervals and reliable escalation pathways.
CMS billing rules make the distinction between collecting data and furnishing a service especially relevant. For applicable RPM services, Medicare requires documented medical necessity and appropriate practitioner involvement; billing requirements also specify minimum data-transmission and treatment-management conditions for particular codes. Organizations should confirm current CMS rules and payer contracts rather than assume that device transmission alone qualifies as reimbursable care.
Digital access and unequal burden
A monitoring program can fail patients who lack reliable broadband, a compatible phone, accessible instructions, language support, or confidence using a device. The Federal Communications Commission has documented persistent gaps in broadband availability, while the U.S. Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology has highlighted digital access and usability as important dimensions of health equity. When connectivity problems are treated as patient noncompliance, the program may widen rather than reduce disparities.
Practical safeguards include cellular-enabled devices where appropriate, technical support, translated materials, accessible interfaces, caregiver involvement with consent, and non-digital alternatives. Programs should track missing readings by factors such as age, language, disability, geography, and payer to identify systematic barriers instead of blaming individuals.
How to prevent skipped RPM data from becoming a safety gap
A reliable RPM program treats data handling as a clinical service with assigned responsibility, not as a dashboard that clinicians are expected to check whenever time permits. The following practices connect technology, staffing, and patient support.
Set thresholds and response ownership
For each monitored condition, define expected measurements, individualized thresholds, review frequency, alert severity, and the person or team accountable for follow-up. The plan should state what happens after hours and how urgent symptoms differ from routine abnormal readings. Patients should be told clearly that RPM is not an emergency-response service unless the program explicitly provides one.
Separate missing data from abnormal data
Dashboards and work queues should distinguish a normal reading, an out-of-range reading, a late reading, and no reading. Automatic reminders can help with routine omissions, but repeated gaps may require a staff call to check for illness, equipment trouble, or a change in circumstances. A documented escalation path prevents unresolved gaps from disappearing in an inbox.
Audit outcomes, not just device activity
Programs should evaluate whether data were reviewed on time, alerts received appropriate follow-up, patients could use their equipment, and clinical outcomes improved. Useful measures include transmission completeness, response time by alert severity, successful patient contact, technical-failure rates, emergency visits, and disparities in participation. The National Academy of Medicine’s work on learning health systems supports using routine data to improve care processes while monitoring unintended consequences.
A simple process map can clarify the workflow: patient measurement → secure transmission → automated quality checks → clinical prioritization → assigned review → documented action → follow-up. This sequence is also a useful textual “chart” of where failures occur: each handoff should have an owner, a time expectation, and a recovery plan.
Conclusion: the real cost is a broken response loop
Skipping remote patient monitoring data can carry clinical, financial, operational, and equity consequences, but no single missed reading guarantees harm. The key risk is a broken response loop: data are expected, a meaningful signal or transmission gap appears, and nobody is responsible for resolving it. Evidence from telehealth studies shows potential benefits in some settings, while professional guidance and CMS requirements underscore the need for appropriate review, documentation, and follow-up.
Health systems should define alert thresholds, assign response ownership, distinguish missing readings from normal ones, support patients facing technology barriers, and audit both safety and outcomes. Clinicians and program leaders can start by reviewing one patient pathway from measurement through action and identifying where a signal could be lost. RPM is most valuable not when it gathers the most data, but when useful data reliably inform timely, appropriate care.
Sources: Centers for Medicare & Medicaid Services, Remote Patient Monitoring, https://www.cms.gov/medicare/coverage/telehealth/remote-patient-monitoring; Centers for Disease Control and Prevention, Heart Disease Facts, https://www.cdc.gov/heart-disease/data-research/facts-stats/; American Heart Association, How to Measure Your Blood Pressure at Home, https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/monitoring-your-blood-pressure-at-home; Agency for Healthcare Research and Quality, Patient Safety, https://www.ahrq.gov/patient-safety/index.html; U.S. Food and Drug Administration, Clinical Decision Support Software, https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software; Steventon et al., Effect of Telehealth on Use of Secondary Care and Mortality: Findings From the Whole System Demonstrator Cluster Randomised Trial, The New England Journal of Medicine, 2012, https://www.nejm.org/doi/full/10.1056/NEJMoa1106862; Federal Communications Commission, 2024 Section 706 Report, https://www.fcc.gov/reports-research/reports/broadband-progress-reports/2024-broadband-deployment-report; Office of the National Coordinator for Health Information Technology, Health Equity by Design, https://www.healthit.gov/topic/health-equity; National Academy of Medicine, The Learning Health System Series, https://nam.edu/programs/value-science-driven-health-care/learning-health-system-series/.
